Compendium of Cancer Genome Aberrations

HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 2,141: Line 2,141:
|NEW (No Prior)
|NEW (No Prior)
|-
|-
|[[HAEM5:Autoimmune lymphoproliferative syndrome|Autoimmune lymphoproliferative syndrome]]||Disease||Aviv Oren, MD (trainee), mentor needed
|[[HAEM5:Autoimmune lymphoproliferative syndrome|Autoimmune lymphoproliferative syndrome]]||Disease||Aviv Oren, MD (trainee), Karin Miller, MD
| || || || ||SK|| ||
|3/25/2024
| || || ||SK|| ||
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
Line 2,182: Line 2,183:
|Disease
|Disease
|Parastou Tizro (trainee) + Sumi Kitahara
|Parastou Tizro (trainee) + Sumi Kitahara
|3/17/24
|3/17/2024
|
|
|Pending
|Pending
Line 2,196: Line 2,197:
|-
|-
|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS
|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS
|3/17/24
|3/17/2024
|6/30/24
|6/30/24
|Pending
|Pending
Line 2,208: Line 2,209:
|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Hailee St. Louis (trainee);  
|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Hailee St. Louis (trainee);  
Michelle Don, MD, MS
Michelle Don, MD, MS
|3/17/24
|3/17/2024
|6/30/24
|6/30/24
|Pending
|Pending
Line 2,226: Line 2,227:
|
|
|-
|-
|[[HAEM5:Sezary syndrome|Sezary syndrome]]||Disease||PENDING
|[[HAEM5:Sezary syndrome|Sezary syndrome]]||Disease||Daynna J. Wolff, PhD
| || || || ||SK|| ||
|3/22/2024
| || || ||SK|| ||
|Sézary Syndrome
|Sézary Syndrome
|Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina
|Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina
Line 2,243: Line 2,245:
|-
|-
|[[HAEM5:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]||Disease||Amanda Xu, MD/MSc
|[[HAEM5:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]||Disease||Amanda Xu, MD/MSc
|3/19/24
|3/19/2024
| ||Pending
| ||Pending
| ||SK|| ||
| ||SK|| ||
Line 2,259: Line 2,261:
|NEW (No Prior)
|NEW (No Prior)
|-
|-
|[[HAEM5:Mycosis fungoides|Mycosis fungoides]]||Disease||PENDING
|[[HAEM5:Mycosis fungoides|Mycosis fungoides]]||Disease||Daynna J. Wolff, PhD
| || || || ||SK|| ||
|3/22/2024
| || || ||SK|| ||
|Mycosis Fungoides
|Mycosis Fungoides
|Jane Scribner, MD and Daynna J. Wolff, PhD
|Jane Scribner, MD and Daynna J. Wolff, PhD
Line 2,283: Line 2,286:
|-
|-
|[[HAEM5:Subcutaneous panniculitis-like T-cell lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]||Disease||Raniah Alamri (Hemepath trainee)
|[[HAEM5:Subcutaneous panniculitis-like T-cell lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]||Disease||Raniah Alamri (Hemepath trainee)
|3/19/24
|3/19/2024
| ||Pending
| ||Pending
| ||SK|| ||
| ||SK|| ||
Line 2,330: Line 2,333:
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee),  
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee),  
Andrew Siref, MD
Andrew Siref, MD
|3/20/24
|3/20/2024
| ||Pending|| ||SK|| ||
| ||Pending|| ||SK|| ||
|Enteropathy-Associated T-cell Lymphoma
|Enteropathy-Associated T-cell Lymphoma
Line 2,340: Line 2,343:
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee),  
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee),  
Andrew Siref, MD
Andrew Siref, MD
|3/20/24
|3/20/2024
| ||Pending|| ||SK|| ||
| ||Pending|| ||SK|| ||
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Line 2,358: Line 2,361:
|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Forough Sargolzaeiaval (trainee);  
|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Forough Sargolzaeiaval (trainee);  
Michelle Don, MD, MS
Michelle Don, MD, MS
|3/19/24
|3/19/2024
|6/30/24
|6/30/24
|Pending
|Pending
Line 2,425: Line 2,428:
|
|
|-
|-
|[[HAEM5:Peripheral T-cell lymphoma, NOS|Peripheral T-cell lymphoma, NOS]]||Disease|| || || || || ||SK|| ||
|[[HAEM5:Peripheral T-cell lymphoma, NOS|Peripheral T-cell lymphoma, NOS]]||Disease||Bo Hong, MD
|6/25/2023
| || || ||SK|| ||
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
Line 2,432: Line 2,437:
|NEW (No Prior)
|NEW (No Prior)
|-
|-
|[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee), Andrew Siref, MD||3/22/24|| ||Pending|| ||SK|| ||
|[[HAEM5:EBV-positive nodal T- and NK-cell lymphoma|EBV-positive nodal T- and NK-cell lymphoma]]||Disease||Fnu Monika, MBBS (trainee), Andrew Siref, MD||3/22/2024|| ||Pending|| ||SK|| ||
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
Line 2,440: Line 2,445:
|-
|-
|[[HAEM5:Extranodal NK/T-cell lymphoma|Extranodal NK/T-cell lymphoma]]||Disease||Amanda Xu, MD/MSc
|[[HAEM5:Extranodal NK/T-cell lymphoma|Extranodal NK/T-cell lymphoma]]||Disease||Amanda Xu, MD/MSc
|3/19/24
|3/19/2024
| ||Pending
| ||Pending
| ||SK|| ||
| ||SK|| ||
Line 2,463: Line 2,468:
|NEW (No Prior)
|NEW (No Prior)
|-
|-
|[[HAEM5:Systemic chronic active EBV disease|Systemic chronic active EBV disease]]||Disease|| || || || || ||SK|| ||
|[[HAEM5:Systemic chronic active EBV disease|Systemic chronic active EBV disease]]||Disease||Karin Miller, MD
| || || || ||SK|| ||
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
Line 2,470: Line 2,476:
|NEW (No Prior)
|NEW (No Prior)
|-
|-
|[[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood|Systemic EBV-positive T-cell lymphoma of childhood]]||Disease||
|[[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood|Systemic EBV-positive T-cell lymphoma of childhood]]||Disease||Karin Miller, MD
| || || || ||SK|| ||prior authors not available
| || || || ||SK|| ||prior authors not available
|Systemic EBV-Positive T-cell Lymphoma of Childhood
|Systemic EBV-Positive T-cell Lymphoma of Childhood
Retrieved from "https://test.ccga.io/index.php/HAEM5:Volunteer_Assignments_and_Opportunities"